Complement C5aR1 Signaling Promotes Polarization and Proliferation of Embryonic Neural Progenitor Cells through PKCζ

• Published in: The Journal of neuroscience Vol. 37; no. 22; pp. 5395 - 5407
• Main Authors: Coulthard, Liam G, Hawksworth, Owen A, Li, Rui, Balachandran, Anushree, Lee, John D, Sepehrband, Farshid, Kurniawan, Nyoman, Jeanes, Angela, Simmons, David G, Wolvetang, Ernst, Woodruff, Trent M
• Format: Journal Article
• Language: English
• Published: United States Society for Neuroscience 31-05-2017
• Subjects: Abnormalities; Animal models; Animals; Brain; Cell Polarity - physiology; Cell proliferation; Cell Proliferation - physiology; Cells (biology); Cells, Cultured; Complement; Complement activation; Complement Activation - physiology; Complement component C5a; Embryogenesis; Embryonic growth stage; Embryonic Stem Cells - cytology; Embryonic Stem Cells - physiology; Embryos; Female; Gene Expression Regulation, Developmental - physiology; Histogenesis; Humans; Immunity; Inhibition; Innate immunity; Kinases; Magnetic resonance imaging; Male; Males; Mammals; Mice; Mice, Inbred C57BL; Mutation; Neural stem cells; Neural Stem Cells - cytology; Neural Stem Cells - physiology; Neurodevelopmental disorders; Neurogenesis; Neurogenesis - physiology; Organic chemistry; Polarity; Progenitor cells; Protein kinase C; Protein Kinase C - metabolism; Proteins; Receptor, Anaphylatoxin C5a - metabolism; Signaling; Stem cells; Ventricle; Ventricular zone; neurogenesis; aPKC; complement; C5a; C5aR1; polarity
• ISSN: 0270-6474; 1529-2401
• DOI: 10.1523/JNEUROSCI.0525-17.2017

The complement system, typically associated with innate immunity, is emerging as a key controller of nonimmune systems including in development, with recent studies linking complement mutations with neurodevelopmental disease. A key effector of the complement response is the activation fragment C5a, which, through its receptor C5aR1, is a potent driver of inflammation. Surprisingly, C5aR1 is also expressed during early mammalian embryogenesis; however, no clearly defined function is ascribed to C5aR1 in development. Here we demonstrate polarized expression of C5aR1 on the apical surface of mouse embryonic neural progenitor cells
and on human embryonic stem cell-derived neural progenitors. We also show that signaling of endogenous C5a during mouse embryogenesis drives proliferation of neural progenitor cells within the ventricular zone and is required for normal brain histogenesis. C5aR1 signaling in neural progenitors was dependent on atypical protein kinase C ζ, a mediator of stem cell polarity, with C5aR1 inhibition reducing proliferation and symmetric division of apical neural progenitors in human and mouse models. C5aR1 signaling was shown to promote the maintenance of cell polarity, with exogenous C5a increasing the retention of polarized rosette architecture in human neural progenitors after physical or chemical disruption. Transient inhibition of C5aR1 during neurogenesis in developing mice led to behavioral abnormalities in both sexes and MRI-detected brain microstructural alterations, in studied males, demonstrating a requirement of C5aR1 signaling for appropriate brain development. This study thus identifies a functional role for C5a-C5aR1 signaling in mammalian neurogenesis and provides mechanistic insight into recently identified complement gene mutations and brain disorders.
The complement system, traditionally known as a controller of innate immunity, now stands as a multifaceted signaling family with a broad range of physiological actions. These include roles in the brain, where complement activation is associated with diseases, including epilepsy and schizophrenia. This study has explored complement regulation of neurogenesis, identifying a novel relationship between the complement activation peptide C5a and the neural progenitor proliferation underpinning formation of the mammalian brain. C5a was identified as a regulator of cell polarity, with inhibition of C5a receptors during embryogenesis leading to abnormal brain development and behavioral deficits. This work demonstrates mechanisms through which dysregulation of complement causes developmental disease and highlights the potential risk of complement inhibition for therapeutic purposes in pregnancy.